Development of endothelial-targeted CD39 as a therapy for ischemic stroke.
Lee NT, Savvidou I, Selan C, Calvello I, Vuong A, Wright DK, Brkljaca R, Willcox A, Chia JSJ, Wang X, Peter K, Robson SC, Medcalf RL, Nandurkar HH, Sashindranath M.
Lee NT, et al. Among authors: brkljaca r.
J Thromb Haemost. 2024 May 14:S1538-7836(24)00281-2. doi: 10.1016/j.jtha.2024.04.023. Online ahead of print.
J Thromb Haemost. 2024.
PMID: 38754782